Oramed Pharmaceuticals
ORMP
#9146
Rank
C$0.24 B
Marketcap
C$5.58
Share price
5.12%
Change (1 day)
70.07%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): C$87.17 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of C$89.05 Million, an increase over its 2024 earnings that were of -C$21.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$87.17 M-2.11%
2025 C$89.05 M-513.21%
2024 -C$21.56 Million-311.47%
2023 C$10.19 M-119.45%
2022 -C$52.4 Million39.17%
2021 -C$37.65 Million73.93%
2020 -C$21.65 Million18.53%
2019 -C$18.27 Million-16.62%
2018 -C$21.91 Million38.32%
2017 -C$15.84 Million12.51%
2016 -C$14.08 Million25.01%
2015 -C$11.26 Million18.18%
2014 -C$9.53 Million39.72%
2013 -C$6.82 Million46.4%
2012 -C$4.66 Million128.32%
2011 -C$2.04 Million-51.47%
2010 -C$4.21 Million35.21%
2009 -C$3.11 Million
2007 -C$4.89 Million607.04%
2006 -C$0.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
C$32.87 B 36,485.33%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
C$11.14 B 12,296.78%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-C$0.64 Billion-811.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-C$87.43 Million-197.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
C$49.89 M-44.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel